DE vs NKTR · P/E 25, rev $35.59B vs rev $21.0M
Deere & Company (DE) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Deere & Company (DE) is a farm & heavy construction machinery company listed on US. It is led by John May.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported DE revenue for 2026-08-02 was $35.59B. Net income was $3.81B. Revenue was up 54.9% from 2026-05-03 to 2026-08-02. DE currently screens at market cap $137.72B and trailing P/E 24.6.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
DE currently screens at market cap $137.72B and trailing P/E 24.6. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the DE and NKTR stock pages for the full models.
Not investment advice.